Clinical Trial Update: Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Jaktinib hydrochloride tablets for severe alopecia areata has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Jaktinib hydrochloride tablets (Jaktinib hydrochloride)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED